Hand, Foot and Mouth Disease – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Hand, Foot and Mouth Disease – Drugs In Development, 2024 report and make more profitable business decisions.
Hand, foot and mouth disease (HFMD) is an illness that causes sores in or on the mouth and on the hands, feet, and legs. Hand, foot and mouth disease is most commonly caused by coxsackievirus A16, a member of the enterovirus family. Symptoms include fever, headache, loss of appetite, and ulcers in the throat (including tonsils), mouth, and tongue. Treatment includes antibiotics and pain relievers.
The Hand, Foot and Mouth Disease drugs in development market research report provide comprehensive information on the therapeutics under development for Hand, Foot and Mouth Disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Hand, Foot and Mouth Disease and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Hand, Foot and Mouth Disease | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 23 molecules, with 15 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Hand, Foot and Mouth Disease therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Hand, Foot and Mouth Disease pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Hand, Foot and Mouth Disease treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
Adimmune CorpAIM Vaccine Co Ltd
Beijing Health Guard Biotechnology Inc
Changchun Bcht Biotechnology Co Ltd
Chinese Academy of Sciences
Chongqing Bovax Biopharmaceutical Co Ltd
Chongqing Zhifei Biological Products Co Ltd
Duke University
Emergex Vaccines Holding Ltd
Genome Institute of Singapore
Griffith University
Institut Pasteur of Shanghai Chinese Academy of Sciences
Intravacc BV
Jiangsu Kanion Pharmaceutical Co Ltd
Jiangsu Recbio Technology Co Ltd
Peking University
Quratis Inc
Shanghai Zerun Biotechnology Co Ltd
Shenzhen Kangtai Biological Products Co Ltd
Sinovac Biotech Ltd
Xiamen University
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Hand, Foot and Mouth Disease reports